A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis

Hypertension-associated end-organ damage commonly leads to cardiac and renal fibrosis. As no effective anti-fibrotic therapy currently exists, the unchecked progression of fibrogenesis manifests as cardio-renal failure and early death. We have previously shown that FATp300—p300 with intrinsic factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Rai, Rahul, Verma, Suresh K., Kim, David, Ramirez, Veronica, Lux, Elizabeth, Li, Chengjin, Sahoo, Susmita, Wilsbacher, Lisa D., Vaughan, Douglas E., Quaggin, Susan E., Ghosh, Asish K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788418/
https://www.ncbi.nlm.nih.gov/pubmed/28933600
http://dx.doi.org/10.1080/15592294.2017.1370173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788418/
https://www.ncbi.nlm.nih.gov/pubmed/28933600
http://dx.doi.org/10.1080/15592294.2017.1370173

Ejemplares similares